BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 6207262)

  • 1. Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors.
    Rock KL; Benacerraf B; Abbas AK
    J Exp Med; 1984 Oct; 160(4):1102-13. PubMed ID: 6207262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen presentation by hapten-specific B lymphocytes. II. Specificity and properties of antigen-presenting B lymphocytes, and function of immunoglobulin receptors.
    Abbas AK; Haber S; Rock KL
    J Immunol; 1985 Sep; 135(3):1661-7. PubMed ID: 2410498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier-independent hapten recognition and promiscuous MHC restriction by CD4 T cells induced by trinitrophenylated peptides.
    Kohler J; Hartmann U; Grimm R; Pflugfelder U; Weltzien HU
    J Immunol; 1997 Jan; 158(2):591-7. PubMed ID: 8992972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-reactive trinitrophenylated peptides as antigens for class II major histocompatibility complex-restricted T cells and inducers of contact sensitivity in mice. Limited T cell receptor repertoire.
    Kohler J; Martin S; Pflugfelder U; Ruh H; Vollmer J; Weltzien HU
    Eur J Immunol; 1995 Jan; 25(1):92-101. PubMed ID: 7843258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of anti-hapten antibody responses by hapten-specific cytolytic T lymphocytes: role of I-A-associated antigen on target B lymphocytes.
    Moser G; Burakoff SJ; Abbas AK
    J Immunol; 1982 Jul; 129(1):63-9. PubMed ID: 6177761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen presentation by hapten-specific B lymphocytes. IV. Comparative ability of B cells to present specific antigen and anti-immunoglobulin antibody.
    Lichtman AH; Tony HP; Parker DC; Abbas AK
    J Immunol; 1987 May; 138(9):2822-5. PubMed ID: 3494773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen presentation by hapten-specific B lymphocytes. III. Analysis of the immunoglobulin-dependent pathway of antigen presentation to interleukin 1-dependent T lymphocytes.
    Rock KL; Haber SI; Liano D; Benacerraf B; Abbas AK
    Eur J Immunol; 1986 Nov; 16(11):1407-12. PubMed ID: 2946591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of hapten-anchoring peptides in defining hapten-epitopes for MHC-restricted cytotoxic T cells. Cross-reactive TNP-determinants on different peptides.
    Martin S; Ortmann B; Pflugfelder U; Birsner U; Weltzien HU
    J Immunol; 1992 Oct; 149(8):2569-75. PubMed ID: 1383319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engagement of the B lymphocyte antigen receptor induces presentation of intrinsic immunoglobulin peptides on major histocompatibility complex class II molecules.
    Bartnes K; Hannestad K
    Eur J Immunol; 1997 May; 27(5):1124-30. PubMed ID: 9174601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen presentation by hapten-specific B lymphocytes. V. Requirements for activation of antigen-presenting B cells.
    Liano D; Abbas AK
    J Immunol; 1987 Oct; 139(8):2562-6. PubMed ID: 2958554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-mediated B cell antigen processing. Increased antigenicity of a globular protein covalently coupled to antibodies specific for B cell surface structures.
    Casten LA; Pierce SK
    J Immunol; 1988 Jan; 140(2):404-10. PubMed ID: 2447176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activation of murine antigen-specific memory B cells by a T-dependent antigen.
    Yefenof E; Sanders VM; Uhr JW; Vitetta ES
    J Immunol; 1986 Jul; 137(1):85-90. PubMed ID: 2423612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-affinity IgE receptor (CD23) function on mouse B cells: role in IgE-dependent antigen focusing.
    Kehry MR; Yamashita LC
    Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7556-60. PubMed ID: 2529541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusion of human B cell lines with HIV-1 envelope-expressing T cells is enhanced by antigen-specific Ig receptors. Possible mechanism for elimination of gp120-specific B cells in vivo.
    Golding H; Dimitrov DS; Blackburn R; Manischewitz J; Blumenthal R; Golding B
    J Immunol; 1993 Mar; 150(6):2506-16. PubMed ID: 7680694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T lymphocyte-mediated suppression of myeloma function in vitro. II. Evidence for regulation of hapten-binding myelomas by syngeneic hapten-specific cytolytic T lymphocytes.
    Abbas AK; Ratnofsky SE; Burakoff SJ
    J Exp Med; 1980 Aug; 152(2):306-23. PubMed ID: 6156985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal anergy of memory B cells in epitope-specific regulation.
    Galelli A; Charlot B
    J Immunol; 1990 Oct; 145(8):2397-405. PubMed ID: 1698854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carrier-directed anti-hapten responses by B-cell subsets.
    Lewis GK; Goodman JW
    J Exp Med; 1977 Jul; 146(1):1-10. PubMed ID: 68986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal analysis of antigen-specific interactions between T cells and genetically engineered B cells.
    Kitagami K; Hozumi N; Ochi A
    Cell Immunol; 1987 Sep; 108(2):438-51. PubMed ID: 2957069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of proteolytic processing during specific antigen presentation.
    Yoshikawa M; Watanabe M; Hozumi N
    Cell Immunol; 1987 Dec; 110(2):431-5. PubMed ID: 2961464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purified MHC class I molecules present hapten-conjugated peptides to TNP/H-2Kb-specific T cell hybridomas.
    von Bonin A; Martin S; Plaga S; Hebbelmann S; Weltzien HU
    Immunol Lett; 1993 Jan; 35(1):63-8. PubMed ID: 7681423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.